PROTEIMER
Biopharmaceutical preparations for the treatment of cancer and neurological and neurodegenerative diseases; therapeutic proteins, namely, targeted binding proteins engineered for high-affinity and specificity to disease-associated targets, for use in modulating cellular signaling pathways and disease progression; biologic preparations for the treatment of oncological, neurological, metabolic, and immunological disorders; aptamer-based therapeutic agents for targeted treatment of cancer, inclu...
Pending · October 7, 2025 · 99431659 ·